Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Government Contract opportunity was posted on August 17, 2017. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Notice of Intent to Sole Source Intramuscular Cyanide Countermeasure Development

Closed
W81XWH-17-SN-0002Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

General Info

Agency

N/A

NAICS

541711 - Research and Development in Biotechnology

Place of Performance

Not specified

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed
Posted

special-notice

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyN/A
Contacts2 people available
OfficeN/A
Organization / Agency
N/A
Office AddressN/A

Full Description

Show more
This is a notice of intent to issue an award on the basis of other than full and open competition in accordance with the Federal Acquisition Regulation (FAR) 13.106(b) where only one source is reasonably available to provide the required research and development services. The U.S. Army Medical Research Acquisition Activity (USAMRAA), Institute for Chemical Defense (ICD) intends to issue a single source award to Southwest Research Institute (SWRI) located at 6220 Culebra Road, San Antonio, TX. The total award amount is estimated to be $100,000.00. The requirement is to continue development of a cyanide countermeasure for intramuscular (IM) delivery. The period of performance will be one base year and two option years. See the attached draft of the Performance Work Statement for additional information. Only SWRI is reasonably available to develop the dimethyl trisulfide (DMTS) countermeasure into an intramuscular delivery system as they were the only company to develop the DMTS compound under contract W81XWH-14-P-0650. THIS NOTICE OF INTENT IS NOT A REQUEST FOR COMPETITIVE QUOTATIONS and no solicitation exists for this requirement. However, parties interested in responding to this notice shall submit technical data, including cost, sufficient to determine capability in providing the same service. All capability statements received by closing of this notification of this synopsis will be considered by the Government. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Responses should be furnished electronically to susan.e.ruzicka2.civ@mail.mil no later than 11:00AM Eastern Standard Time, 01 September 2017.

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS